← Open Payments lookup

NPI 1164410650: Open Payments

NPI 1164410650. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,354 in 64 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $452 · 2025 $1,354

Food & beverage: $1,354
CompanyPaymentsAmount
ABBVIE INC.15$272
PROTEGA PHARMACEUTIALS INC4$226
Salix Pharmaceuticals, a division of Bausch Health US, LLC15$178
Novartis Pharmaceuticals Corporation7$151
Takeda Pharmaceuticals U.S.A., Inc.4$106
PFIZER INC.4$87
ARGENX US, INC.2$67
Eisai Inc.2$48
Medtronic, Inc.2$37
Biogen, Inc.1$28

Products named: ROXYBOND, UBRELVY, RELISTOR, KESIMPTA, HYQVIA, QULIPTA, Leqembi, ZAVZPRET.